Jessica Jensen

Chief Tech/Sci/R&D Officer at

POINT Biopharma, Inc. (United States)

46 year

16 connections

Health Technology

Consumer Services

Commercial Services

Profile

Jessica Jensen is currently the Executive Vice President-Clinical Development at POINT Biopharma, Inc. in the United States.
Prior to this, she was the Senior Vice President-Clinical Development at Progenics Pharmaceuticals, Inc. from 2018 to 2020.
She will also be the Executive Vice President-Clinical Development at POINT Biopharma Global, Inc. from 2021 to 2023.
Ms. Jensen has a graduate degree from George Washington University and an undergraduate degree from St. Joseph's University.

Jessica Jensen active positions

Companies	Position	Start
POINT Biopharma, Inc. (United States) POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer	Chief Tech/Sci/R&D Officer	01/08/2020

All active positions of Jessica Jensen

Former positions of Jessica Jensen

Companies	Position	End
POIT BIOP	Chief Tech/Sci/R&D Officer	27/12/2023
PROGENICS PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/08/2020

See the detail of Jessica Jensen's experience

Training of Jessica Jensen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jessica Jensen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Progenics Pharmaceuticals, Inc. Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer	Health Technology
George Washington University George Washington University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
St. Joseph's University St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
POINT Biopharma Global, Inc. POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer	Health Technology
POINT Biopharma, Inc. (United States) POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer	Commercial Services